drugset

drugset / Trial / NCT06408519

Open-Label Placebo for Non-Specific Pain in the ED

NCT06408519 ↗

Completed 57 enrolled Bruno Minotti Anna Szczesna, Co-investigator, University Hospital Basel, Emergency Department · collab Bojana Degen, Co-investigator, University of Basel, Faculty of Psychology · collab Christian H Nickel, Co-investigator, Deputy Head of Emergency Department, University Hospital Basel · collab Jens Gaab, Co-investigator, Head of Division University of Basel, Faculty of Psychology · collab Roland Bingisser, Principal Investigator, Head of Emergency Department, University Hospital Basel · collab

RandomizedParallel-groupOpen-labelOther

Summary

The aim of this study is to assess whether an intervention with open-label placebo (OLP) for non-specific pain in the emergency department is feasible.

Timeline

Start: 2024-05-23
Primary completion: 2026-02-13
Completion: 2026-02-13

Publications

Degen B, Szczesna A, Nickel CH, Bingisser R, Gaab J, Minotti B. Open-label placebo for non-specific pain in the emergency department (OLP EM): study protocol for a mixed-method randomised control feasibility study in Switzerland. BMJ Open. 2025 Mar 25;15(3):e090508. doi: 10.1136/bmjopen-2024-090508.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Ibuprofen	Small molecule	400 mg	—

Indications

No indication recorded.